These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22929978)

  • 1. B-lymphopoiesis is stopped by mobilizing doses of G-CSF and is rescued by overexpression of the anti-apoptotic protein Bcl2.
    Winkler IG; Bendall LJ; Forristal CE; Helwani F; Nowlan B; Barbier V; Shen Y; Cisterne A; Sedger LM; Levesque JP
    Haematologica; 2013 Mar; 98(3):325-33. PubMed ID: 22929978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation.
    Winkler IG; Pettit AR; Raggatt LJ; Jacobsen RN; Forristal CE; Barbier V; Nowlan B; Cisterne A; Bendall LJ; Sims NA; Lévesque JP
    Leukemia; 2012 Jul; 26(7):1594-601. PubMed ID: 22266913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myeloma.
    Steinberg M; Silva M
    Clin Ther; 2010 May; 32(5):821-43. PubMed ID: 20685493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of G-CSF and AMD3100 mobilizes bone marrow-derived stem cells to protect against cisplatin-induced acute kidney injury in mice.
    Chen Z; Ren X; Ren R; Wang Y; Shang J
    Stem Cell Res Ther; 2021 Mar; 12(1):209. PubMed ID: 33761993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
    Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
    J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures.
    Donahue RE; Jin P; Bonifacino AC; Metzger ME; Ren J; Wang E; Stroncek DF
    Blood; 2009 Sep; 114(12):2530-41. PubMed ID: 19602709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle.
    Wright DE; Cheshier SH; Wagers AJ; Randall TD; Christensen JL; Weissman IL
    Blood; 2001 Apr; 97(8):2278-85. PubMed ID: 11290588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin Modifies Responses to Hematopoietic Stem Cell Mobilizing Agents in Mice.
    Danner E; Bonig H; Wiercinska E
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of stem cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor on morphology of haematopoietic organs in mice.
    Szumilas P; Barcew K; Baśkiewicz-Masiuk M; Wiszniewska B; Ratajczak MZ; Machaliński B
    Cell Prolif; 2005 Feb; 38(1):47-61. PubMed ID: 15679866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cells and liver regeneration: differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury.
    Tsolaki E; Athanasiou E; Gounari E; Zogas N; Siotou E; Yiangou M; Anagnostopoulos A; Yannaki E
    Blood Cells Mol Dis; 2014 Sep; 53(3):124-32. PubMed ID: 24923531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF.
    Gazitt Y; Akay C; Thomas C
    Stem Cells Dev; 2006 Apr; 15(2):269-77. PubMed ID: 16646673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate mimetics can efficiently mobilize long-term hematopoietic stem cells.
    Di Giacomo F; Lewandowski D; Cabannes E; Nancy-Portebois V; Petitou M; Fichelson S; Romeo PH
    Haematologica; 2012 Apr; 97(4):491-9. PubMed ID: 22180429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide reciprocally alters the stromal cell-regulated positive and negative balance between myelopoiesis and B lymphopoiesis in C57BL/6 mice.
    Taki M; Tsuboi I; Harada T; Naito M; Hara H; Inoue T; Aizawa S
    Biol Pharm Bull; 2014; 37(12):1872-81. PubMed ID: 25451836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of hematopoietic progenitor cell mobilization from bone marrow by granulocyte colony stimulating factor and AMD3100 and chemotaxis into the brain using stromal cell-derived factor-1α in an Alzheimer's disease mouse model.
    Shin JW; Lee JK; Lee JE; Min WK; Schuchman EH; Jin HK; Bae JS
    Stem Cells; 2011 Jul; 29(7):1075-89. PubMed ID: 21608078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Acting IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Granulocyte Colony-Stimulating Factor or AMD3100.
    Alt C; Yuan S; Wu F; Stankovich B; Calaoagan J; Schopies S; Wu JY; Shen J; Schneider D; Zhu Y; Zhao XY; Lippow SM; Bauzon M
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1475-1485. PubMed ID: 31163266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In senescence, age-associated B cells secrete TNFα and inhibit survival of B-cell precursors.
    Ratliff M; Alter S; Frasca D; Blomberg BB; Riley RL
    Aging Cell; 2013 Apr; 12(2):303-11. PubMed ID: 23410004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
    Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW
    Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
    Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
    J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.
    Flomenberg N; Devine SM; Dipersio JF; Liesveld JL; McCarty JM; Rowley SD; Vesole DH; Badel K; Calandra G
    Blood; 2005 Sep; 106(5):1867-74. PubMed ID: 15890685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone and bone-marrow interactions: haematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. Mobilizing properties on white blood cells and peripheral blood stem cells in mice.
    Fazzi R; Testi R; Trasciatti S; Galimberti S; Rosini S; Piras F; L'Abbate G; Conte A; Petrini M
    Leuk Res; 2002 Jan; 26(1):19-27. PubMed ID: 11734300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.